NFKB1 and metabolic dysfunction-associated steatotic liver disease: Knocking out STING in HFD-induced NAFLD and MCD-induced NASH murine models attenuated hepatic activation of IRF3 and NF-κB pathways, and significantly downregulated expression of pro-inflammatory cytokines to alleviate NAFLD/NASH severity [148].